Cross-sectional study to characterize cohorts of subjects with asthma and healthy controls in terms of clinical features, physiological measurements and non-invasive measurement of biomarkers and develop phenotype handprints for adults with severe asthma
Study Type
OBSERVATIONAL
Enrollment
725
Asthma exacerbations
Number, duration and severity of exacerbations over the time of the study
Time frame: 3 years
Lung function decline over the course of the study
Time frame: 3 years
Changes in asthma medication
in particular ICS dose, over the duration of the study
Time frame: 3 years
Daily symptoms and short acting beta agonist (SABA) usage
measured during the telemonitoring study
Time frame: 3 years
Asthma control questionnaire (ACQ) at baseline and changes over the course of the study
Time frame: 3 years
Upper airway symptoms as assessed by the sino-nasal outcomes test (SNOT) at baseline and changes over the course of the study
Time frame: 3 years
Sleep and daytime drowsiness as assessed by the Epworth sleepiness scale at baseline and changes over the course of the study
Time frame: 3 years
Measurement of pulmonary function including spirometry, plethysmography, bronchodilator reversibility and respiratory impedance by forced oscillation technique
Time frame: 3 years
Radiological parameters such as computerized tomography (CT) scan, including assessment of lung structure
Time frame: 3 years
Measurement of inflammatory cell counts in blood, sputum and bronchoalveolar lavage (BAL)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3 years
Histopathology of bronchial biopsies in a sub group of subjects
immunohistochemistry for inflammatory cells and matrix remodelling
Time frame: 3 years
Transcriptomics, proteomics and metabolomics will be used on samples such as blood, urine and endobronchial biopsies
to develop clinically useful phenotype handprints
Time frame: 3 years
Quality of life as assessed by the asthma quality of life questionnaire (AQLQ)
Time frame: 3 years
Anxiety and depression as assessed by the hospital anxiety and depression scale (HADS)
Time frame: 3 years